Cargando…

PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer

E-cadherin, a transmembrane adhesion molecule, and phosphatase of regenerating liver 3 (PRL-3) protein, a member of the family of tyrosine phosphatases, seem to be responsible for cancer cell migration. Therefore, the study objective was to determine a correlation between PRL-3 and E-cadherin, to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Pryczynicz, Anna, Guzińska-Ustymowicz, Katarzyna, Niewiarowska, Katarzyna, Cepowicz, Dariusz, Kemona, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107272/
https://www.ncbi.nlm.nih.gov/pubmed/24696260
http://dx.doi.org/10.1007/s13277-014-1855-7
_version_ 1782327577076039680
author Pryczynicz, Anna
Guzińska-Ustymowicz, Katarzyna
Niewiarowska, Katarzyna
Cepowicz, Dariusz
Kemona, Andrzej
author_facet Pryczynicz, Anna
Guzińska-Ustymowicz, Katarzyna
Niewiarowska, Katarzyna
Cepowicz, Dariusz
Kemona, Andrzej
author_sort Pryczynicz, Anna
collection PubMed
description E-cadherin, a transmembrane adhesion molecule, and phosphatase of regenerating liver 3 (PRL-3) protein, a member of the family of tyrosine phosphatases, seem to be responsible for cancer cell migration. Therefore, the study objective was to determine a correlation between PRL-3 and E-cadherin, to assess their expression in neoplastic tissue and normal mucosa of the stomach, to analyze their effect on cancer advancement, and to evaluate their potential as prognostic markers in gastric cancer. The expressions of PRL-3 and E-cadherin were assessed immunohistochemically in 71 patients with gastric cancer. Positive expression of PRL-3 was observed in 42.2 % of gastric cancer cases, whereas E-cadherin expression was abnormal in 38 % of cases. The study revealed that the positive PRL-3 expression and abnormal E-cadherin expression were associated with mucinous gastric carcinoma and lymph node involvement. The former was also related to the infiltrating type of tumor and abnormal E-cadherin expression. The expression of PRL-3, but not of E-cadherin, was associated with shorter survival of patients. PRL-3 and E-cadherin exhibit interactions in gastric cancer and are involved in the formation of lymph node metastases. The PRL-3 protein can be an independent predictive factor of overall survival in gastric cancer patients.
format Online
Article
Text
id pubmed-4107272
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-41072722014-08-08 PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer Pryczynicz, Anna Guzińska-Ustymowicz, Katarzyna Niewiarowska, Katarzyna Cepowicz, Dariusz Kemona, Andrzej Tumour Biol Research Article E-cadherin, a transmembrane adhesion molecule, and phosphatase of regenerating liver 3 (PRL-3) protein, a member of the family of tyrosine phosphatases, seem to be responsible for cancer cell migration. Therefore, the study objective was to determine a correlation between PRL-3 and E-cadherin, to assess their expression in neoplastic tissue and normal mucosa of the stomach, to analyze their effect on cancer advancement, and to evaluate their potential as prognostic markers in gastric cancer. The expressions of PRL-3 and E-cadherin were assessed immunohistochemically in 71 patients with gastric cancer. Positive expression of PRL-3 was observed in 42.2 % of gastric cancer cases, whereas E-cadherin expression was abnormal in 38 % of cases. The study revealed that the positive PRL-3 expression and abnormal E-cadherin expression were associated with mucinous gastric carcinoma and lymph node involvement. The former was also related to the infiltrating type of tumor and abnormal E-cadherin expression. The expression of PRL-3, but not of E-cadherin, was associated with shorter survival of patients. PRL-3 and E-cadherin exhibit interactions in gastric cancer and are involved in the formation of lymph node metastases. The PRL-3 protein can be an independent predictive factor of overall survival in gastric cancer patients. Springer Netherlands 2014-04-03 /pmc/articles/PMC4107272/ /pubmed/24696260 http://dx.doi.org/10.1007/s13277-014-1855-7 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Research Article
Pryczynicz, Anna
Guzińska-Ustymowicz, Katarzyna
Niewiarowska, Katarzyna
Cepowicz, Dariusz
Kemona, Andrzej
PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer
title PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer
title_full PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer
title_fullStr PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer
title_full_unstemmed PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer
title_short PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer
title_sort prl-3 and e-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107272/
https://www.ncbi.nlm.nih.gov/pubmed/24696260
http://dx.doi.org/10.1007/s13277-014-1855-7
work_keys_str_mv AT pryczyniczanna prl3andecadherinshowmutualinteractionsandparticipateinlymphnodemetastasisformationingastriccancer
AT guzinskaustymowiczkatarzyna prl3andecadherinshowmutualinteractionsandparticipateinlymphnodemetastasisformationingastriccancer
AT niewiarowskakatarzyna prl3andecadherinshowmutualinteractionsandparticipateinlymphnodemetastasisformationingastriccancer
AT cepowiczdariusz prl3andecadherinshowmutualinteractionsandparticipateinlymphnodemetastasisformationingastriccancer
AT kemonaandrzej prl3andecadherinshowmutualinteractionsandparticipateinlymphnodemetastasisformationingastriccancer